Stock screenerAll disclosures →
EDGAR →
NATR
Conviction 28HealthcareScan · Mon, Aug 10, 2026NATR$15.78-3.69%
ResistanceSupportVol 14Insider sellVol MA14 202.24K
May 11May 28Jun 16Jul 6Jul 23Aug 10
Price15.78
Change-3.69%
Gap-0.55%
Rel volume4.79×
Avg volume168.7K
Avg $ vol3.15M
SMA 2020.17
SMA 5020.53
SMA 20022.42
Price vs 50-23.15%
Price vs 200-29.64%
MA stackbearish
50/200 cross—
Supertrenddown · 19.27
RSI (14)23
MACD hist-0.45
MACD crossbear · 3d
Stoch %K / %D3 / 18
ADX (14)23
+DI / −DI12 / 40
RSI divergenceBullish
MACD divergence—
ATR %+6.45%
ADR %3.84%
52w high27.80
52w low13.14
From 52w high-43.26%
Above 52w low+20.05%
New 52w highNo
SqueezeOff
Bollinger width27.82%
%B-0.28
Donchian pos2.68%
Donchian high21.76
Donchian low15.61
AVWAP (52w high)22.03
vs AVWAP high-28.38%
AVWAP (52w low)22.19
vs AVWAP low-28.90%
OBV trendDown
Chaikin MF (20)-0.07
Today vs 20d4.79×
Avg vol (14d)202.24K
Avg vol (20d)168.7K
Avg $ vol (20d)3.15M
Market cap277.57M
RS 3m (vs SPY)-38.98%
RS 6m (vs SPY)-51.69%
RS line new highNo
Trend template2/8
Technical rank6.5
1 week-25.38%
1 month-25.83%
3 months-34.89%
6 months-40.09%
1 year+2.77%
YTD-24.77%
P/E14.22
P/B2.03
P/S0.58
P/FCF9.62
EPS1.06
Div yield—
ROE14.29%
ROA7.51%
Debt/Eq0.00
Current2.60
EV/EBITDA5.06
Gross margin72.42%
Net margin4.07%
Rev growth5.67%
EPS growth153.65%
Price target—
Target upside—
Analyst rating—
Institutional—
Ent. value195.07M
Revenue116.98M
Net income3.54M
Gross profit86.17M
Free cash flow28.84M
IndustryPHARMACEUTICAL PREPARATIONS
ExchangeNasdaq
Shares out17.58M
Employees806
ListedThu, Aug 7, 1980
Free float14.44M
Float %82.1%
Short interest505.74K
Days to cover5.1d
Short volume66.2%
Squeeze score64 / 100
Next earnings—
EPS forecast—
Last EPS vs est—
Last surprise—
Setup gradeD
Conviction28 / 100
Pattern quality—
Tech rank6.5 / 100
Group rank86 / 100 · Leading
Status laneNo active setup
Setup direction—
Pattern family
Resistance22.07
Support19.73
Days since event—
Candle confirm—
News sentiment—
Financials as of Tue, Jun 30, 2026 · quarterly.
Congress activity
Disclosed STOCK Act trades in NATR
No recent disclosed trades by Congress in NATR. STOCK Act filings can lag the trade by up to 45 days.
Insider activity
SEC Form 4 transactions in NATR · 7 buys · 3 sells
| Insider | Side | Shares | Value | Traded | Filed |
|---|---|---|---|---|---|
Herbert Kevin R. EVP & President, North America · Common Shares · 2026-06-26 | Tax | 1.98K | $42K | 2026-06-26 | 2026-06-29 |
Norman Daniel C EVP & President, Asia · Common Shares · 2026-06-01 | Sell | 9.71K | $200K | 2026-06-01 | 2026-06-03 |
Brower Nathan G EVP, General Counsel · Common Shares · 2026-05-21 | Sell | 12.02K | $262K | 2026-05-21 | 2026-05-22 |
Fasching Steven J. Director · Common Shares · 2026-05-15 | Grant | 4.5K | $0 | 2026-05-15 | 2026-05-20 |
Yang Rong Director · Common Shares · 2026-05-15 | Grant | 4.5K | $0 | 2026-05-15 | 2026-05-19 |
Wissmiller Heidi Director · Common Shares · 2026-05-15 | Grant | 4.5K | $0 | 2026-05-15 | 2026-05-19 |
Straus Robert D Director · Common Shares · 2026-05-15 | Grant | 4.5K | $0 | 2026-05-15 | 2026-05-19 |
Brower Nathan G EVP, General Counsel · Common Shares · 2026-05-15 | Grant | 9K | $0 | 2026-05-15 | 2026-05-19 |
Norman Daniel C EVP & President, Asia · Common Shares · 2026-05-15 | Grant | 11.38K | $0 | 2026-05-15 | 2026-05-19 |
Fuller Kevin Gregory Global Chief Marketing Officer · Common Shares · 2026-05-15 | Grant | 8.98K | $0 | 2026-05-15 | 2026-05-19 |
SEC filings
EDGAR filings in NATR · 2 recent
Get daily signals & real-time alerts.
StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.
Start free — 14-day full access →Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.